Literature DB >> 30207576

Management of Psoriatic Arthritis: Turkish League Against Rheumatism (TLAR) Expert Opinions.

Kemal Nas1, Erkan Kiliç2, Remzi Çevik3, Hatice Bodur4, Şebnem Ataman5, Figen Ayhan6,7, Özgür Akgül8, Ayşen Akinci9, Zuhal Altay10, Erhan Çapkın11, Abdullah Zübeyir Dağli12, Tuncay Duruöz13, Gülcan Gürer14, Feride Göğüş15, Yeşim Garip16, Cahit Kaçar17, Ayhan Kamanli18, Ece Kaptanoğlu19, Taciser Kaya20, Hilal Kocabaş21, Erhan Ali Özdemirel22, Sumru Özel23, İlhan Sezer24, İsmihan Sunar5, Gürkan Yilmaz5.   

Abstract

OBJECTIVES: This study aims to establish the first national treatment recommendations by the Turkish League Against Rheumatism (TLAR) for psoriatic arthritis (PsA) based on the current evidence. PATIENTS AND METHODS: A systematic literature review was performed regarding the management of PsA. The TLAR expert committee consisted of 13 rheumatologists and 12 physical medicine and rehabilitation specialists experienced in the treatment and care of patients with PsA from 22 centers. The TLAR recommendations were built on those of European League Against Rheumatism (EULAR) 2015. Levels of evidence and agreement were determined.
RESULTS: Recommendations included five overarching principles and 13 recommendations covering therapies for PsA, particularly focusing on musculoskeletal involvement. Level of agreement was greater than eight for each item.
CONCLUSION: This is the first paper that summarizes the recommendations of TLAR as regards the treatment of PsA. We believe that this paper provides Turkish physicians dealing with PsA patients a practical guide in their routine clinical practice.

Entities:  

Keywords:  Expert opinions; Turkish League Against Rheumatism; management; psoriatic arthritis; treatment recommendation

Year:  2018        PMID: 30207576      PMCID: PMC6117146          DOI: 10.5606/ArchRheumatol.2018.6946

Source DB:  PubMed          Journal:  Arch Rheumatol        ISSN: 2148-5046            Impact factor:   1.472


  158 in total

1.  Healthcare and burden of disease in psoriatic arthritis. A comparison with rheumatoid arthritis and ankylosing spondylitis.

Authors:  Angela Zink; Katja Thiele; Doerte Huscher; Joachim Listing; Joachim Sieper; Andreas Krause; Erika Gromnica-Ihle; Ulrich von Hinueber; Siegfried Wassenberg; Ekkehard Genth; Matthias Schneider
Journal:  J Rheumatol       Date:  2006-01       Impact factor: 4.666

Review 2.  Therapies for psoriatic enthesopathy. A systematic review.

Authors:  Christopher T Ritchlin
Journal:  J Rheumatol       Date:  2006-05-15       Impact factor: 4.666

3.  Magnetic resonance imaging guided corticosteroid injection of the sacroiliac joints in patients with therapy resistant spondyloarthropathy: a pilot study.

Authors:  I Günaydin; P L Pereira; T Daikeler; M Mohren; J Trübenbach; F Schick; L Kanz; I Kötter
Journal:  J Rheumatol       Date:  2000-02       Impact factor: 4.666

Review 4.  Pro-inflammatory cytokines and adipose tissue.

Authors:  S W Coppack
Journal:  Proc Nutr Soc       Date:  2001-08       Impact factor: 6.297

5.  The role of NSAIDs in psoriatic arthritis: evidence from a controlled study with nimesulide.

Authors:  P Sarzi-Puttini; S Santandrea; L Boccassini; B Panni; I Caruso
Journal:  Clin Exp Rheumatol       Date:  2001       Impact factor: 4.473

6.  Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis.

Authors:  M C Kapetanovic; T Saxne; A Sjöholm; L Truedsson; G Jönsson; P Geborek
Journal:  Rheumatology (Oxford)       Date:  2005-11-15       Impact factor: 7.580

7.  Progression of peripheral joint disease in psoriatic arthritis: a 5-yr prospective study.

Authors:  N J McHugh; C Balachrishnan; S M Jones
Journal:  Rheumatology (Oxford)       Date:  2003-03-14       Impact factor: 7.580

Review 8.  Cardiovascular and gastrointestinal effects of COX-2 inhibitors and NSAIDs: achieving a balance.

Authors:  Jeffrey S Borer; Lee S Simon
Journal:  Arthritis Res Ther       Date:  2005-09-15       Impact factor: 5.156

9.  Dactylitis in psoriatic arthritis: a marker for disease severity?

Authors:  J E Brockbank; M Stein; C T Schentag; D D Gladman
Journal:  Ann Rheum Dis       Date:  2004-07-22       Impact factor: 19.103

10.  A prospective, clinical and radiological study of early psoriatic arthritis: an early synovitis clinic experience.

Authors:  D Kane; L Stafford; B Bresnihan; O FitzGerald
Journal:  Rheumatology (Oxford)       Date:  2003-10-01       Impact factor: 7.580

View more
  2 in total

1.  Residual symptoms and disease burden among patients with psoriatic arthritis: is a new disease activity index required?

Authors:  Gamze Kilic; Erkan Kilic; Kemal Nas; Ayhan Kamanlı; İbrahim Tekeoglu
Journal:  Rheumatol Int       Date:  2018-11-13       Impact factor: 2.631

2.  Neuropathic Pain: Unexplored and Significant Relationship With Psoriatic Arthritis and Functional Parameters.

Authors:  Çağrı Ünal Ulutatar; Fırat Ulutatar; Mehmet Tuncay DuruÖz
Journal:  Arch Rheumatol       Date:  2019-12-17       Impact factor: 1.472

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.